Risk Tolerance of Therapeutic Interventions in People with Parkinson’s Disease
Objective: To determine the sociodemographic factors of people with Parkinson’s disease (PD) associated with risk tolerance when considering interventions. Background: Gender and racial disparities in…Unilateral Deep Brain Stimulation in Parkinson’s Disease: Long-term Efficacy and Bilateral Symptom Progression
Objective: To investigate the long-term efficacy of unilateral deep brain stimulation and the progression of motor symptoms on the untreated side in Parkinson's disease (PD)…Connectivity-Based Analysis of the Impact of GPi Deep Brain Stimulation on the Freezing of Gait in Parkinson’s Disease
Objective: We aim to investigate the association between structural connectivity and its influence on the freezing of gait (FOG) after globus pallidus internus (GPi) deep…Clinically implemented sensing-based initial programming of deep brain stimulation for Parkinson’s disease: a retrospective study
Objective: We aimed to assess the feasibility and performance of clinically implemented sensing-based initial deep brain stimulation (DBS) programming for Parkinson’s disease (PD). Background: Initial…A comparative study of focused ultrasound unilateral thalamotomy and subthalamotomy for medication refractory Parkinsonian tremor
Objective: Unilateral focused ultrasound (FUS) thalamotomy of the ventral intermediate thalamic nucleus (FUS-Vim) is effective in treating Parkinson’s disease (PD) tremor. FUS ablation of the…Evaluation of the results of neuromodulation of the Subthalamic Nucleus (STN) in patients with Parkinson’s Disease (PD) depending on the anesthesia used during stereotactic electrode implantation.
Objective: Comparison of the efficacy of STN neuromodulation after surgical intervention with Monitored Anesthesia Care (MAC) and using general anesthesia (GA). Background: The effectiveness of…Clinical Trends and Clinician Perceptions Regarding Asleep and Awake DBS
Objective: To determine trends and perceptions regarding Asleep and Awake Deep Brain Stimulation (DBS) in the USA and abroad. Background: DBS clinical practice continues to…Regional Brain Volume Differences Across PD Clinical Subtypes
Objective: To investigate brain morphometric differences across Parkinson disease (PD) clinical subtypes. Background: We developed a PD subtype classification with three subtypes that includes motor…Serum levels of VEGF-C and ENDGLIN in Parkinson’s disease and their clinical relevance
Objective: To evaluate the differences in serum concentrations of neurovascular unit (NVU)-related cytokines between patients with Parkinson's disease (PD) and control subjects (Ctr) and to…24 Hour Maxillofacial Administration of Levodopa in a Parkinsons Patient -An Alternative Route of Administration in Parkinsons Disease
Objective: To assess tolerability, feasibility, safety and to assess outcome measures clinically as well as by serum levels over 24 hours, using the alternative maxillofacial…
- « Previous Page
- 1
- …
- 447
- 448
- 449
- 450
- 451
- …
- 1942
- Next Page »